Evidence map›Paper›PMID 32296580›Full record

ArticleCancer biology & medicine2020

Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway.

Yulong Lan, Jiacheng Lou, Jiliang Hu, Zhikuan Yu, Wen Lyu, Bo Zhang

Open access · goldAbstract read
In one paragraph

Article in Cancer biology & medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. New prognostic biomarkerAnnals of translational medicine · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yulong LanDepartment of Neurosurgery, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.
Jiacheng LouDepartment of Neurosurgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Jiliang HuDepartment of Neurosurgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Zhikuan YuDepartment of Neurosurgery, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.
Wen LyuDepartment of Neurosurgery, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.ORCID 0000-0002-8130-6022
Bo ZhangDepartment of Neurosurgery, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.ORCID 0000-0001-6635-6577
Jinan University · CNDalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CNSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAnimalsBrainBrain NeoplasmsCell Line, TumorDown-RegulationDrug Resistance, NeoplasmFemaleGene Expression Regulation, NeoplasticGene Knockdown TechniquesGlioblastomaHumansMaleMiceMiddle AgedMYC protein, humanProto-Oncogene Proteins c-mycsnRNP Core ProteinsSNRPG protein, humanTemozolomideTP53 protein, humanTumor Suppressor Protein p53cell cycleglioblastomaSNRPGtemozolomidetherapy

Identifiers

PMID32296580
PMCPMC7142844
OpenAlexW3019450950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.